Microbot Medical Inc.
General ticker "MBOT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $54.5M (TTM average)
Microbot Medical Inc. follows the US Stock Market performance with the rate: 34.4%.
Estimated limits based on current volatility of 5.2%: low 2.32$, high 2.58$
Factors to consider:
- Total employees count: 22 (+4.8%) as of 2023
- Top business risk factors: Going concern, Profitability concerns, Product development risks, Regulatory and compliance, Limited operating history
- Current price 48.9% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.63$, 1.65$]
- 2025-12-31 to 2026-12-31 estimated range: [0.60$, 1.56$]
Financial Metrics affecting the MBOT estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -54.61 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 58.53 <= 63.39
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 9.51 > -0.66
- Positive: Inventory ratio change, % of 0 <= 0
Short-term MBOT quotes
Long-term MBOT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $13.28MM | $9.86MM | $11.62MM |
| Operating Income | $-13.28MM | $-9.86MM | $-11.62MM |
| Non-Operating Income | $0.11MM | $-0.89MM | $0.18MM |
| R&D Expense | $7.74MM | $5.72MM | $6.63MM |
| Income(Loss) | $-13.17MM | $-10.74MM | $-11.44MM |
| Profit(Loss)* | $-13.17MM | $-10.74MM | $-11.44MM |
| Stockholders Equity | $7.29MM | $4.50MM | $3.53MM |
| Assets | $9.54MM | $8.33MM | $6.03MM |
| Operating Cash Flow | $-11.55MM | $-8.53MM | $-8.83MM |
| Capital expenditure | $0.08MM | $0.03MM | $0.03MM |
| Investing Cash Flow | $-3.84MM | $1.97MM | $1.54MM |
| Financing Cash Flow | $4.32MM | $6.56MM | $7.94MM |
| Earnings Per Share** | $-1.81 | $-1.05 | $-0.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.